Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
INTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resist...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2014/537948 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849304435459620864 |
|---|---|
| author | Shiona K Glass-Kaastra Rita Finley Jim Hutchinson David M Patrick Karl Weiss John Conly |
| author_facet | Shiona K Glass-Kaastra Rita Finley Jim Hutchinson David M Patrick Karl Weiss John Conly |
| author_sort | Shiona K Glass-Kaastra |
| collection | DOAJ |
| description | INTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important. |
| format | Article |
| id | doaj-art-1374bd01840b41bca3bdc22649f572c9 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-1374bd01840b41bca3bdc22649f572c92025-08-20T03:55:44ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-0125210711210.1155/2014/537948Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010Shiona K Glass-Kaastra0Rita Finley1Jim Hutchinson2David M Patrick3Karl Weiss4John Conly5Public Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario, CanadaPublic Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario, CanadaDivision of Medical Microbiology, Island Medical Program, University of British Columbia, Vancouver, British Columbia, CanadaBritish Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, CanadaDepartment of Infectious Diseases and Microbiology, University of Montreal, Hôpital Maisonneuve-Rosemont, Montreal, CanadaDepartment of Medicine, University of Calgary, Calgary, Alberta, CanadaINTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important.http://dx.doi.org/10.1155/2014/537948 |
| spellingShingle | Shiona K Glass-Kaastra Rita Finley Jim Hutchinson David M Patrick Karl Weiss John Conly Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 |
| title_full | Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 |
| title_fullStr | Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 |
| title_full_unstemmed | Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 |
| title_short | Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 |
| title_sort | longitudinal surveillance of outpatient β lactam antimicrobial use in canada 1995 to 2010 |
| url | http://dx.doi.org/10.1155/2014/537948 |
| work_keys_str_mv | AT shionakglasskaastra longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 AT ritafinley longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 AT jimhutchinson longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 AT davidmpatrick longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 AT karlweiss longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 AT johnconly longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010 |